Anna Franzone - Concepedia

Author

Anna Franzone

Also Known As

A C Franzone, A Franzone, A. Franzone, Anna Franzone, Enoch F Akowuah, Franzone, Anna, Giovanni Sposito, Josè del Carmen Rojas, Victoria Delgado

227

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Bern University of Bern University of Naples Federico II Institute of Social and Preventive Medicine Federico II University Hospital

About

Anna Franzone is an author at University Hospital of Bern specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.4K
2	Public Health	8	8	446
3	Engineering	3	3	126
4	Health Sciences	1	1	31
5	Natural Sciences	1	1	11

Anna Franzone

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy Roberta Roncarati, Chiara Viviani Anselmi, Maria Angela Losi, Journal of the American College of Cardiology CardiomyopathyHeart FailureBoth HypertrophyOther Up-regulated MicrornasCardiovascular Disease	2013	318
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting Anna Franzone, Eugène McFadden, Sergio Leonardi, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacologyCardiology	2019	145
Frequency, Timing, and Impact of Access-Site and Non–Access-Site Bleeding on Mortality Among Patients Undergoing Transcatheter Aortic Valve Replacement Raffaele Piccolo, Thomas Pilgrim, Anna Franzone, JACC: Cardiovascular Interventions Cardiovascular DiseaseNon–access-site BleedingPatient SafetyVascular SurgeryOutcomes Research	2017	143
Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial Roberto Galea, Federico De Marco, Nicolas Méneveau, Circulation	2021	131
Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement Masahiko Asami, Stefan Stortecky, Fabien Praz, JACC. Cardiovascular imaging Right Ventricular DysfunctionHeart FailureCardiovascular DiseasePrognostic ValueValve Disease	2018	117
Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity Konstantinos C. Koskinas, George C.M. Siontis, Raffaele Piccolo, Circulation Cardiovascular Interventions	2016	116
Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis Stefan Stortecky, Anna Franzone, Dik Heg, European Heart Journal - Quality of Care and Clinical Outcomes	2018	93
Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease Anna Franzone, Raffaele Piccolo, Giuseppe Gargiulo, JAMA Cardiology	2016	86
The Impact of Left Ventricular Diastolic Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement Masahiko Asami, Jonas Lanz, Stefan Stortecky, JACC: Cardiovascular Interventions Heart FailureCardiovascular DiseaseValve DiseaseClinical OutcomesSurgery	2018	71
Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial Rainer Zbinden, Raffaele Piccolo, Dik Heg, Journal of the American Heart Association	2016	68

Page 1